• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计并一锅合成噻唑基腙衍生物作为流感神经氨酸酶抑制剂。

Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.

机构信息

College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.

Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

出版信息

Mol Divers. 2017 Aug;21(3):565-576. doi: 10.1007/s11030-017-9740-0. Epub 2017 May 23.

DOI:10.1007/s11030-017-9740-0
PMID:28536876
Abstract

Two series of novel 2-thiazolylhydrazone derivatives were designed and synthesized via one-pot reaction of benzaldehyde derivatives, [Formula: see text]-haloketones and thiosemicarbazide. The structures of compounds 1 and 2 were characterized by [Formula: see text] NMR and [Formula: see text] NMR, and compound 1g was further confirmed by X-ray crystallography. All of the target compounds were evaluated for their NA inhibitory activity against influenza viral neuraminidase (H1N1) in vitro, and the results showed that many compounds exhibited moderate to strong inhibitory activities against influenza viral neuraminidase (H1N1). Among them, compounds 1p, 1q and 2c showed the most potent inhibitory activities with [Formula: see text] values ranging from 10.50 to [Formula: see text]. Our structure-activity relationship analysis indicated that 2-thiazolylhydrazone is an effective scaffold for NA inhibitors and that introducing an ethoxycarbonyl group to the 5-position of thiazole ring could enhance inhibitory potency. Molecular docking was performed on the most active compounds 1p and 2c to provide more insight into their mechanism of interaction.

摘要

设计并合成了两个系列的新型 2-噻唑基腙衍生物,其通过一锅法反应由苯甲醛衍生物、[化学式:见正文] -卤代酮和氨基硫脲制备得到。化合物 1 和 2 的结构通过 [化学式:见正文] NMR 和 [化学式:见正文] NMR 进行了表征,化合物 1g 还通过 X 射线晶体学进行了进一步确认。所有目标化合物都进行了抗甲型流感病毒神经氨酸酶(H1N1)的体外抑制活性评估,结果表明,许多化合物对流感病毒神经氨酸酶(H1N1)表现出中等至较强的抑制活性。其中,化合物 1p、1q 和 2c 表现出最强的抑制活性,[化学式:见正文] 值范围为 10.50 至 [化学式:见正文]。我们的构效关系分析表明,2-噻唑基腙是神经氨酸酶抑制剂的有效骨架,在噻唑环的 5 位引入乙氧羰基可以增强抑制活性。对最活跃的化合物 1p 和 2c 进行了分子对接,以提供其相互作用机制的更多见解。

相似文献

1
Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.设计并一锅合成噻唑基腙衍生物作为流感神经氨酸酶抑制剂。
Mol Divers. 2017 Aug;21(3):565-576. doi: 10.1007/s11030-017-9740-0. Epub 2017 May 23.
2
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.设计、合成及 4-噻唑啉酮衍生物作为流感神经氨酸酶抑制剂的生物活性评价。
Eur J Med Chem. 2021 Mar 5;213:113161. doi: 10.1016/j.ejmech.2021.113161. Epub 2021 Jan 12.
3
Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.设计和合成 4-烷基-2-氨基(乙酰氨基)-6-芳基-1,3-噻嗪衍生物作为流感神经氨酸酶抑制剂。
Arch Pharm (Weinheim). 2013 Sep;346(9):635-44. doi: 10.1002/ardp.201300122. Epub 2013 Aug 7.
4
Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.阿魏酸衍生物的流感神经氨酸酶抑制剂的生物测定。
Arch Pharm (Weinheim). 2020 Jan;353(1):e1900174. doi: 10.1002/ardp.201900174. Epub 2019 Oct 28.
5
Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors.设计、合成及噻唑衍生物作为新型流感神经氨酸酶抑制剂的生物活性。
J Enzyme Inhib Med Chem. 2011 Aug;26(4):506-13. doi: 10.3109/14756366.2010.534732. Epub 2010 Dec 14.
6
Design, synthesis and neuraminidase inhibitory activity of 4-methyl-5-(3-phenylacryloyl) thiazoles.4-甲基-5-(3-苯丙烯酰基)噻唑的设计、合成及神经氨酸酶抑制活性。
Mol Divers. 2024 Jun;28(3):1129-1140. doi: 10.1007/s11030-023-10639-1. Epub 2023 Mar 23.
7
Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.酰基胍型奥司他韦羧酸盐衍生物作为强效神经氨酸酶抑制剂的发现。
Bioorg Med Chem. 2017 May 15;25(10):2772-2781. doi: 10.1016/j.bmc.2017.03.052. Epub 2017 Mar 27.
8
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.三维定量构效关系和对接研究黄酮衍生物作为流感 H1N1 病毒神经氨酸酶的有效抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5964-70. doi: 10.1016/j.bmcl.2011.07.071. Epub 2011 Jul 26.
9
In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.通过分子对接、抗病毒评估以及利用核磁共振进行的膜相互作用研究寻找有效的甲型H1N1流感病毒神经氨酸酶抑制剂。
Acta Virol. 2018;62(2):179-190. doi: 10.4149/av_2018_209.
10
Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.新型扎那米韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3622-3629. doi: 10.1016/j.bmcl.2018.10.040. Epub 2018 Oct 26.

本文引用的文献

1
Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.对多种蛋白质-配体复合物上的十种对接程序进行综合评估:采样能力和评分能力的预测准确性。
Phys Chem Chem Phys. 2016 May 14;18(18):12964-75. doi: 10.1039/c6cp01555g. Epub 2016 Apr 25.
2
Avian Influenza A(H5N1) Virus in Egypt.埃及的甲型H5N1禽流感病毒
Emerg Infect Dis. 2016 Mar;22(3):379-88. doi: 10.3201/eid2203.150593.
3
Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.
利用支持向量机和朴素贝叶斯模型发现甲型流感病毒神经氨酸酶抑制剂
Mol Divers. 2016 May;20(2):439-51. doi: 10.1007/s11030-015-9641-z. Epub 2015 Dec 21.
4
Predicting dual-targeting anti-influenza agents using multi-models.使用多模型预测双靶点抗流感药物
Mol Divers. 2015 Feb;19(1):123-34. doi: 10.1007/s11030-014-9552-4. Epub 2014 Oct 2.
5
The challenges of global case reporting during pandemic A(H1N1) 2009.2009年甲型H1N1流感大流行期间全球病例报告面临的挑战。
Bull World Health Organ. 2014 Jan 1;92(1):60-7. doi: 10.2471/BLT.12.116723. Epub 2013 Aug 23.
6
Oseltamivir for control of influenza at mass gatherings.用于在大型集会中控制流感的奥司他韦。
Infect Disord Drug Targets. 2013 Feb;13(1):46-52. doi: 10.2174/18715265112129990007.
7
Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses.新型甲型 H7N9 流感病毒致人类感染的起源与多样性:系统发育、结构和合并分析。
Lancet. 2013 Jun 1;381(9881):1926-32. doi: 10.1016/S0140-6736(13)60938-1. Epub 2013 May 1.
8
Shifting from the single to the multitarget paradigm in drug discovery.从单靶点到多靶点药物研发的转变。
Drug Discov Today. 2013 May;18(9-10):495-501. doi: 10.1016/j.drudis.2013.01.008. Epub 2013 Jan 20.
9
Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics.通过对接分子动力学产生的非活性激酶构象发现酪氨酸激酶抑制剂。
ChemMedChem. 2012 Nov;7(11):1983-90. doi: 10.1002/cmdc.201200331. Epub 2012 Sep 13.
10
Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.合成及某些新型 1-茚酮噻唑腙衍生物作为抗克氏锥虫试剂的生物评价。
Eur J Med Chem. 2012 Sep;55:155-63. doi: 10.1016/j.ejmech.2012.07.013. Epub 2012 Jul 20.